Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese by Lee, Kelvin Y.C. et al.
Association of LOXL1 polymorphisms with pseudoexfoliation in
the Chinese
Kelvin Y.C. Lee,1,4 Su Ling Ho,2 Anbupalam Thalamuthu,3 Anandalakshmi Venkatraman,4
Divya Venkataraman,4 Don C.K. Pek,2 Tin Aung,1,4,5 Eranga N. Vithana4
(The first two authors contributed equally to this work and are joint first authors.)
1Singapore National Eye Centre, Singapore; 2Department of Ophthalmology, Tan Tock Seng Hospital, Singapore; 3Genome Institute
of Singapore, Singapore; 4Singapore Eye Research Institute, Singapore; 5Department of Ophthalmology, Yong Loo Lin School of
Medicine, National University of Singapore, Singapore
Purpose:  Single  nucleotide  polymorphisms  (SNPs)  within  the  lysyl  oxidase  like-1  gene  (LOXL1;  rs1048661  and
rs3825942) were found to confer risk to pseudoexfoliation glaucoma (XFG) through the pseudoexfoliation syndrome
(XFS) in Nordic, Caucasian, and two Asiatic populations (Indian and Japanese). The prevalence (0.2%–0.7%) of XFS in
the Chinese is considerably lower compared to Nordic populations. The aim of this study was to determine the association
of LOXL1 in Chinese subjects with XFS/XFG.
Methods: Chinese subjects with clinically diagnosed XFS/XFG and normal controls were recruited. Genomic DNA was
extracted, and the two LOXL1 SNPs (rs1048661 and rs3825942) were genotyped by bidirectional sequencing. Allele and
genotype frequencies were compared between cases and unrelated controls using PLINK. Linkage disequilibrium (LD)
calculations and haplotype association analysis were done using the Haploview package and WHAP package, respectively.
Results: Sixty-two Chinese patients (17 XFG and 45 XFS) and 171 Chinese controls were studied. The G allele of LOXL1
SNP rs3825942 was moderately associated (OR=10.97, p=0.0018) with pseudoxfoliation in the Chinese. The frequency
of the G allele of rs1048661 was not significantly different in cases compared to controls (p=0.142) in the allelic association
test. However, the genotype test showed marginal association for rs1048661 (p=0.030). Only three haplotypes were
observed (T-G, G-G, and G-A) with G-G as a risk haplotype (p=0.0034) and G-A as a protective haplotype (p=0.00039).
T-G, which was a risk haplotype in the Japanese, was not associated with XFG in the Chinese (p=0.124).
Conclusions: Polymorphisms in LOXL1 confer risk to XFS/XFG in the Chinese. The lower incidence of XFS compared
to other populations suggests additional genetic or environmental factors to have a major influence on the phenotypic
expression of XFS in the Chinese. The G allele of rs3825942 has been shown to be associated with XFS/XFG in all
populations studied to date.
Pseudoexfoliation syndrome (XFS) is the most common
identifiable cause of open-angle glaucoma worldwide [1]. It
is a condition characterized by abnormal accumulation of
microfibrillar deposits on the surfaces of the pupillary border,
anterior chamber angle, anterior lens capsule, ciliary body,
and zonular fibers [2]. The prevalence of XFS increases with
age [3], and worldwide prevalence rates have been found to
vary in different populations [4-8]. XFS has been reported to
be uncommon in Chinese people with the prevalence of 0.2%
reported in Chinese Singaporean adults aged 40 years and
older [9,10].
XFS is associated with ocular [11] and systemic [12-16]
manifestations including a reported conversion rate of 44% to
pseudoexfoliation glaucoma (XFG) over 15 years [17]. XFG
has a worse prognosis than primary open-angle glaucoma
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(POAG) with high resistance to medical therapy and rapid
progression of glaucomatous optic neuropathy [18].
A recent study demonstrated the association of XFS/XFG
with  three  single  nucleotide  polymorphisms  (SNPs),
rs1048661  (R141L),  rs3825942  (G153D),  and  rs2165241
(intronic), located in the first exon of the lysyl oxidase-like 1
gene (LOXL1) on chromosome 15q24.1 [19]. The two non-
synonymous SNPs, rs1048661 and rs3825942 were highly
associated  with  XFG  (OR=2.46  and  20.10,  respectively).
Subsequent studies replicated the association of LOXL1 SNPs
with XFS/XFG in different populations including Caucasians,
Germans, Italians, Central Europeans, Indians, and Japanese
[20-30]. The association of LOXL1 SNPs seems to be confined
to  XFS/XFG  as  studies  on  POAG  patients  including  the
Chinese population did not report any significant association
[31-34].
Up  to  now,  only  two  Asian  populations,  Indian  and
Japanese, had reported associations with LOXL1 and XFS
[26,28]. While the Indian population showed similar allelic
associations  with  Caucasians,  the  Japanese,  which  we
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1120TABLE 1. DEMOGRAPHIC FEATURES OF SUBJECTS IN THIS STUDY.
Features
Combined pseudoexfoliation
Age (years)
mean±SD 74.7±7.7 67.42±5.6
Range 61–93 58–88
Gender
Male 30 (48.39%) 80 (46.78%)
Female 32 (51.61%) 91 (53.22%)
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 XFS (45) + XFG (17) [n=62]                                        Controls (n=171)
reported  previously,  had  a  reversal  of  the  risk  allele  in
rs1048661 [28]. It is unknown if other Asian populations like
the Chinese have similar associations of LOXL1 with XFS.
Hence, the aim of our study was to evaluate the hitherto
untested  association  of  the  LOXL1  SNPs  rs1048661  and
rs3825942 in Singaporean Chinese subjects with XFS/XFG.
METHODS
Study subjects: Chinese patients with clinically diagnosed
XFS/XFG and normal Chinese controls were recruited from
two tertiary eye care centers, Singapore National Eye Centre
and Tan Tock Seng Hospital, in Singapore. Written informed
consent was obtained from all subjects, and the study protocol
had the approval of the hospitals’ ethics committees and was
performed  according  to  the  tenets  of  the  Declaration  of
Helsinki.
All subjects underwent detailed ophthalmic examinations
by ophthalmologists that included slit-lamp biomicroscopic
examination, gonioscopy, dilated examination of the lens, and
funduscopy. Subjects with XFS were defined as those with
clinical evidence of pseudoexfoliation at the pupil margin,
anterior lens surface, or other anterior segment structures with
an intraocular pressure (IOP) of less than 21 mmHg and no
clinical evidence of glaucomatous optic neuropathy. Subjects
with XFG were defined as those with clinical evidence of XFS
and  glaucomatous  optic  neuropathy  (defined  as  loss  of
neuroretinal rim with a vertical cup:disc ratio of greater than
0.7) with compatible visual field loss. Chinese subjects with
a normal anterior segment and optic nerve examination and
without clinical signs of XFS/XFG were recruited as controls.
Genotyping: Genomic DNA was extracted from peripheral
white blood cells of all subjects. The genotypes of LOXL1
SNPs  rs1048661  and  rs3825942  were  determined  by
polymerase chain reaction (PCR) followed by bidirectional
sequencing as described previously [28].
Statistical analysis: Fisher’s exact tests were used to test the
allelic and genotypic associations of all the SNPs with XFG
and  XFS.  Hardy–Weinberg  equilibrium  (HWE)  of  the
genotypic frequencies among cases and separately among the
controls was also examined. PLINK [35] was used to do the
Fisher’s exact test and the logistic regression adjusting for
other  covariates  and  SNPs.  Linkage  disequilibrium  (LD)
calculations were done using the Haploview package [36].
Haplotype  association  analysis  was  performed  using  the
WHAP package [37]. Joint associations of all the haplotypes
(global test) and haplotype specific (HS) associations were
performed using this program. The haplotype specific test of
association was used to examine the independent effect of any
specific haplotype. For this test, none of the haplotypes was
used under the null model, and the specific haplotype was
entered under the alternative model. A likelihood ratio test
was  then  constructed  to  assess  the  significance  of  the
haplotype  specific  effect.  Assuming  the  highly  prevalent
haplotype as the base line, each of the other haplotype was
also compared with the base-line haplotype using a logistic
regression  model.  The  power  of  our  study  to  detect
associations  was  computed  using  the  QUANTO  software
[38].
RESULTS
Sixty-two Chinese patients (45 XFS and 17 XFG) and 171
Chinese controls were recruited for the study. The mean age
of patients (XFS and XFG) was 74.7±7.7 years (age range
from 61 to 93), and for normal controls, the mean age was
67.4±5.6 (age range from 58 to 88). The difference in age
between  cases  and  controls  was  found  to  be  significant
(p=5.853x10−10),  but  the  gender  frequencies  were  not
(p=0.8824).  The  demographic  characteristics  of  the  study
subjects are shown in Table 1.
The  distribution  of  the  allele  frequencies  for  SNPs
rs1048661 and rs3825942 within LOXL1 are shown in Table
2.  The  Hardy–Weinberg  equilibrium  was  observed  in  the
genotype frequencies for patients and controls. The SNPs
rs1048661  and  rs3825942  were  in  strong  linkage
disequilibrium (D’=1, 95% CI: 0.71–1.0). The G allele of SNP
rs3825942 of LOXL1 was moderately associated (OR=10.97,
The demographic features of the 62 Chinese pseudoexfoliation study subjects and 171 controls are shown. The age range and
mean age with standard deviation (SD) are shown for each cohort. The difference in age between cases and controls was
significant (p=5.853x10−10 ),  but  the  gender  frequencies  were  not  (p=0.8824;  Fisher’s  exact  test).  Abbreviations:
XFS=pseudoexfoliation syndrome; XFG=pseudoexfoliation glaucoma; n=number of subjects.T
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.p=0.0018) with pseudoexfoliation in the Chinese while the
frequency of the G allele of rs1048661 was not significantly
different in cases compared to controls (p=0.142). The age-
and sex-adjusted OR for developing pseudoexfoliation and for
having the G allele at SNP rs3825942 was 16.56 (95% CI:
1.86–144.93, p=0.012). The genotype analysis showed only a
marginal association with rs1048661 (p=0.0304).
The  haplotype  analysis  of  LOXL1  polymorphisms  in
pseudoexfoliation and control subjects are shown in Table 3.
Only three of the four possible haplotypes (T-G, G-G, and G-
A)  were  detected  in  the  haplotype  analysis.  The  G-G
haplotype was a risk haplotype (OR=1.92, p=0.0034) while
the G-A haplotype was observed to be protective (OR=0.08,
p=0.00039).  The  T-G  haplotype  was  not  associated  with
pseudoexfoliation in the Chinese (p=0.124). The two-locus
haplotype frequencies in Chinese, Japanese, and Caucasian
that are based on SNPs rs1048661 and rs3825942 are shown
in Table 4. We have also calculated the haplotype diversity, a
measure of the uniqueness of a particular haplotype in a given
population, for cases and controls of the three populations
[39]. Reflecting the fact that only three haplotypes are present,
the haplotype diversity values were also similar within the
controls  of  all  three  populations,  although  the  frequency
distribution  of  haplotypes  was  somewhat  different.  The
predominance of the T-G haplotype in the Japanese affected
with pseudoexfoliation was reflected in the low haplotype
diversity  value  (H=0.102)  for  this  sample.  The  allele
frequencies of the two non-synonymous SNPs of LOXL1 in
different populations are shown in Table 5.
DISCUSSION
Our  study  showed  that  the  G  allele  of  rs3825942  within
LOXL1 confers a 10 fold risk to XFS/XFG in the Chinese
population.  Genotype  analysis  revealed  that  both  non-
synonymous  SNPs,  rs3825942  and  rs1048661,  were
associated  with  XFS/XFG,  although  the  latter  only
marginally. This result for rs1048661 can be attributed to the
limited power of our study due to small sample size. The
estimated  power  of  our  study  ranged  between  30%–50%,
calculated based on the observed range of allele frequencies,
the odds ratios in our data, prevalence of 0.2%, and a 1:3 case-
control ratio. Since Thorleifsson et al. [19] reported the results
of a genome-wide association study of XFG, which identified
three strongly associated variants of LOXL1, other studies
have replicated the association of the two non-synonymous
variants,  R141L  (rs1048661)  and  G153D  (rs3825942)  in
different  populations.  These  LOXL1  replication  studies  in
various populations have suggested rs3825942 to be the XFS-
associated SNP with the G allele being the universally disease
risk-associated  allele.  The  association  of  rs1048661  with
XFS/XFG is controversial due to several reasons. In all the
Japanese studies conducted to date, the disease associated
allele of rs1048661 was T instead of G as seen in Caucasian
or the Scandinavian studies [27-30]. In other studies such as
the  one  on  an  Asian  population  of  Southern  Indians,  the
sample sizes were too small to detect statistically significant
associations with rs1048661 [26]. However the G allele of
rs3825942 has been shown to be associated with XFS/XFG in
all population studied to date.
To compare our Chinese haplotype data with haplotype
data from a Japanese population and a Caucasian population,
we have shown the frequencies of the two-locus haplotype for
the  three  different  populations  (Table  4).  Our  study  data
conform more with what has been observed in the Caucasian
and the Scandinavian studies than with other Japanese studies,
even though Japanese and Chinese populations may have a
more recent common population history compared to other
populations [40,41]. The T-G haplotype, which was the risk
haplotype in the Japanese population, was not associated with
XFS in the Chinese population in our study. Moreover, the G-
G haplotype, which is a risk haplotype in the Chinese as it is
in Caucasian and the Scandinavian cohorts, is a protective
haplotype in the Japanese. However, the frequencies of the
three main haplotypes (T-G, G-G, and G-A) between Chinese
and Japanese controls are very similar. The T-G haplotype
with a frequency at around 50%–55% is the major haplotype
in both populations whereas in the Nordic and Caucasian
populations, the G-G haplotype is the dominant haplotype
TABLE 3. HAPLOTYPE ANALYSIS OF LOXL1 POLYMORPHISMS IN PSEUDOEXFOLIATION AND CONTROL SUBJECTS.
rs1048661 rs3825942
Haplotype frequency
HS test* 
p value OR* [95%CI] p value** OR** [95%CI]
XFS/XFG
total Controls
T G 0.476 0.556 0.124 1.39 [0.91–2.12] - -
G G 0.516 0.363 0.0034 1.92 [1.25–2.96] 0.018 1.7 [1.1–2.63]
G A 0.008 0.082 0.00039 0.08 [0.01–0.62] 0.031 0.11 [0.01–0.80]
All haplotypes with frequency greater than 1% in the combined case and control sample are shown in the table. The XFS/XFG
total indicates pseudoexfoliation with and without glaucoma. The single asterisk indicates haplotype specific (HS) testing. This
test is a comparison of a specific haplotype with the other two. The double asterisk indicates the p values and OR values derived
from comparing each haplotype with the base-line haplotype (T-G). p values for HS testing are based on 10,000 permutations.
Abbreviations: XFS=pseudoexfoliation syndrome; OR=odds ratio; CI=confidence interval; XFG=pseudoexfoliation glaucoma.
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between the Chinese and Japanese may partly be caused by
some combination of the effects of other unlinked modifier
genes  and  environmental  effects  influencing  the  disease
penetrance in these two populations. The haplotype formed
by  protective  alleles  (T-A)  was  also  not  observed  in  the
Chinese case-control groups, similar to data from other Asian
populations (Indian and Japanese) as well as Scandinavian
and Caucasian populations [19-30].
We also compared the allele frequencies for the G alleles
of rs1048661 and rs3825942 in pseudoexfoliation cases (with
and  without  glaucoma)  and  controls  among  different
populations  (Table  5).  The  minor  allele  frequency  of
rs3825942  was  highest  in  African  Americans.  This  may
reflect geographically varying selective pressures and/or a
much  older  population.  The  minor  allele  frequency  of
rs3825942  was  more  stable  and  considerably  lower  at
approximately  15%  in  all  non-African  populations.  In
comparison, the minor allele frequency of rs1048661 was
higher and more varied across populations. This suggests that
the G153D variation may produce more deleterious alteration
to  the  gene  product  than  R141L  and  that  there  is  higher
selection  against  maintaining  this  polymorphism  in
populations than R141L. The high variability of the minor
allele frequency of rs1048661 may also indicate the influence
of factors such as genetic drift on this allele frequency. It is
interesting  to  note  that  these  minor  alleles  are  protective
against pseudoexfoliation in all populations studied except in
the Japanese where the T allele of rs1048661 was associated
with disease. The frequency of the G allele for SNP rs3825942
at  0.918  is  slightly  high  in  our  control  cohort.  However,
another study that investigated the LOXL1 SNPs in Chinese
POAG patients from Hong Kong and Beijing with a larger
control cohort found the G allele frequency to be 0.876 in their
control group, similar to other Caucasian populations. The
higher frequency of the G allele in our Chinese cohort may be
related to the small sample size. The control group allele
frequencies of the non-synonymous SNPs reported by Gong
et al. in another Chinese sample were generally similar to our
study and may represent the migration of Southern Chinese to
Singapore [34].
The  prevalence  of  XFS/XFG  varies  widely  across
populations,  ranging  from  20%–25%  in  the  Scandinavian
countries of Iceland and Finland [42,43] to less than 1% in the
Chinese and Japanese [7,9,10]. Interestingly, the lowest G
allele frequency for rs3825942 at 0.599 has been observed in
the  African  American  population  where  the  XFS/XFG
prevalence is low at approximately 0.4% [6,31,44]. However,
dissimilarities in risk allele frequencies across populations
alone cannot explain the widely different prevalent rates that
are  observed.  Similar  allelic  architecture  in  different
populations with widely differing disease prevalence has also
TABLE 5. REPORTED ALLELE FREQUENCIES OF LOXL1 POLYMORPHISMS IN PSEUDOEXFOLIATION AND CONTROL SUBJECTS AMONG DIFFERENT POPULATIONS.
Population Phenotype
rs1048661 (G/T) rs3825942 (G/A)
G G
Iceland XFG 0.827 0.987 75 [19]
Controls 0.651 0.847 14474
Sweden XFG 0.834 0.995 199 [19]
Controls 0.682 0.879 198
USA Caucasian XFG 0.787 0.939 50 [20]
Controls 0.665 0.844 235
Australia XFG, XFS 0.78 0.95 86 [21]
Controls 0.66 0.84 2087
Europe (German+Italian) XFG, XFS 0.82 0.965 726 [24]
Controls 0.652 0.851 418
Southern India XFG, XFS 0.72 0.92 52 [26]
Controls 0.63 0.74 97
Japan XFG, XFS 0.053 (T=0.947) 0.99 209 [28]
Controls 0.497 0.86 172
Japan XFG 0.005 (T=0.995) 0.995 95 [30]
Controls 0.47 0.85 190
Singapore (Chinese) XFG, XFS 0.524 0.992 62 Present study
Controls 0.444 0.918 171
Hong Kong (Chinese) Controls 0.472 0.876 250 [34]
African American Controls NA 0.599 97 [31]
Allele frequencies for the G alleles of rs1048661 and rs3825942 in pseudoexfoliation cases (with and without glaucoma) and
controls among different populations are shown. The allele frequencies are shown for normal Chinese controls from Hong Kong
for comparison with our present study. NA: not available.
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Sample size References
Allele frequencybeen  observed  [21].  This  suggests  other  yet  unidentified
genetic and/or environmental factors independent of LOXL1
that influence the penetrance of the disease.
In summary, we found an association of LOXL1 variants
with XFS/XFG in the Chinese. Our study of Chinese subjects
with XFS further supports previous reports that the G allele of
rs3825942 is the universal risk allele associated with XFS.
While we were able to replicate similar results in the Chinese
population, other genetic and/or strong environmental factors
could be modulating the phenotypic expression of XFS in the
Chinese, which results in a lower prevalence of the disease in
this population.
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